Skip to main content
Fig. 1 | Biological Procedures Online

Fig. 1

From: A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers

Fig. 1

Differential expression of CLSPN in pan-cancer. A Expression levels of CLSPN in different TCGA tumors from TIMER database, *P < 0.05; **P < 0.01; ***P < 0.001. B Human CLSPN expression levels in different tumor types derived from the GTEx database (*P < 0.05, **P < 0.01, ***P < 0.001). C Expression levels of CLSPN in 23 tumor cell lines based on the CCLE datasets (Kruskal–Wallis test: P = 2.6e − 24)

Back to article page